Ampio Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Ampio Pharmaceuticals, Inc.‘s stocks are currently a part of 68 hedge funds’ portfolios, which represents 11.92% of the total amount of its stocks outstanding. This makes up a total of 26.95M shares of Ampio Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -11.50% or -3.50M shares fewer. As for the holding position changes, 11.76% (8) of current hedge fund investors increased the number of shares held, 26.47% (18) of current holders sold a part of the shares held, and 32.35% (22) closed the holdings completely. 4 hedge funds are new holders of Ampio Pharmaceuticals, Inc. stock in Q3 2022, it is 5.88% of total holders.
Hedge funds holding Ampio Pharmaceuticals (Q4 2017 – Q3 2022)
| Q4 2017 | 54 |
|---|---|
| Q1 2018 | 70 |
| Q2 2018 | 83 |
| Q3 2018 | 75 |
| Q4 2018 | 83 |
| Q1 2019 | 81 |
| Q2 2019 | 77 |
| Q3 2019 | 71 |
| Q4 2019 | 74 |
| Q1 2020 | 73 |
| Q2 2020 | 75 |
| Q3 2020 | 79 |
| Q4 2020 | 101 |
| Q1 2021 | 108 |
| Q2 2021 | 126 |
| Q3 2021 | 120 |
| Q4 2021 | 128 |
| Q1 2022 | 122 |
| Q2 2022 | 101 |
| Q3 2022 | 68 |
Hedge funds changes in Ampio Pharmaceuticals positions (Q4 2017 – Q3 2022)
| Q4 2017 | 15 | 12 | 10 | 5 | 12 |
|---|---|---|---|---|---|
| Q1 2018 | 24 | 20 | 6 | 8 | 12 |
| Q2 2018 | 31 | 17 | 11 | 18 | 6 |
| Q3 2018 | 8 | 35 | 5 | 16 | 11 |
| Q4 2018 | 20 | 19 | 16 | 12 | 16 |
| Q1 2019 | 7 | 18 | 14 | 9 | 33 |
| Q2 2019 | 14 | 13 | 20 | 16 | 14 |
| Q3 2019 | 10 | 15 | 10 | 16 | 20 |
| Q4 2019 | 11 | 13 | 12 | 8 | 30 |
| Q1 2020 | 11 | 16 | 10 | 9 | 27 |
| Q2 2020 | 11 | 21 | 11 | 7 | 25 |
| Q3 2020 | 16 | 25 | 8 | 13 | 17 |
| Q4 2020 | 28 | 31 | 13 | 6 | 23 |
| Q1 2021 | 18 | 35 | 15 | 9 | 31 |
| Q2 2021 | 38 | 28 | 23 | 21 | 16 |
| Q3 2021 | 7 | 32 | 28 | 12 | 41 |
| Q4 2021 | 16 | 33 | 35 | 8 | 36 |
| Q1 2022 | 8 | 21 | 31 | 14 | 48 |
| Q2 2022 | 20 | 15 | 22 | 38 | 6 |
| Q3 2022 | 4 | 8 | 18 | 22 | 16 |
Hedge funds changes in Ampio Pharmaceuticals stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 2,306,000 | 1,644,000 |
|---|---|---|
| Q1 2018 | 4,007,000 | 2,508,000 |
| Q2 2018 | 719,000 | 485,000 |
| Q3 2018 | 261,000 | 46,000 |
| Q4 2018 | 221,000 | 20,000 |
| Q1 2019 | 204,000 | 7,000 |
| Q2 2019 | 226,000 | 21,000 |
| Q3 2019 | 137,000 | 16,000 |
| Q4 2019 | 138,000 | 21,000 |
| Q1 2020 | 223,000 | 55,000 |
| Q2 2020 | 380,000 | 95,000 |
| Q3 2020 | 784,000 | 323,000 |
| Q4 2020 | 1,936,000 | 1,626,000 |
| Q1 2021 | 2,186,000 | 695,000 |
| Q2 2021 | 2,712,000 | 410,000 |
| Q3 2021 | 1,937,000 | 234,000 |
| Q4 2021 | 646,000 | 109,000 |
| Q1 2022 | 674,000 | 77,000 |
| Q2 2022 | 207,000 | 15,000 |
| Q3 2022 | 62,000 | 1,000 |